BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Swedish Company, Aerocrine to Bring HQs to NC, Will Create 45 New Jobs


3/19/2012 7:53:51 AM

Triangle Business Journal by Amanda Jones Hoyle, Staff Writer

The Swedish medical technology company Aerocrine has announced it will be moving its North American headquarters from New Jersey to Morrisville with plans to create 45 jobs in Wake County.

Aerocrine, which focuses on the treatment of airway diseases such as asthma, has been awarded a $50,000 grant from the One North Carolina Fund, which must also be matched by a local government to qualify.

Chip Neff, president of Aerocrine Inc., said in a news release issued by Gov. Beverly Perdue’s office that the company plans to invest $219,000 in the project over the next three years. Aerocrine salaries for the new positions will average about $69,000 a year, plus benefits. The average annual wage in Wake County is $44,980.

Aerocrine has its corporate headquarters in Stockholm, Sweden, and the company’s stock is traded on the Stockholm Stock Exchange.

The company says its founders were the first to identify nitric oxide as a marker of inflammation, which is the main cause of asthma, and the company has two products that it markets globally, NIOX Flex and NIOX MINO, which are used to diagnosis and treat airways disease.

“We are excited to be moving our North American headquarters to North Carolina,” Neff said in the news release. “The state’s leading position in respiratory disease research and commercialization of cutting edge products was critical in our decision to locate our business in North Carolina.”



Read at Triangle Business Journal
Read at Examiner
Read at NBC

Aerocrine
 
 
Sarcoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES